Infant Leukemia Suggestive of Natural Killer Cell Precursor Origin Followed an Unusual Clinical Course

Publisher： Karger

E-ISSN： 1421-9662|104|4|202-206

ISSN： 0001-5792

Source： Acta Haematologica, Vol.104, Iss.4, 2001-03, pp. : 202-206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD7+ and CD56+ Myeloid/Natural Killer Cell Precursor Acute Leukemia Treated with Idarubicin and Cytosine Arabinoside

By  

Acta Haematologica, Vol. 108, Iss. 1, 2002-07 ,pp. : 47-52

Karger

Access to resources Recommend Favorite

Natural killer cell therapy in children with relapsed leukemia

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 8, 2015-08 ,pp. : 1468-1472

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human Natural Killer Cells: Origin, Receptors, Function, and Clinical Applications

By  

International Archives of Allergy and Immunology, Vol. 164, Iss. 4, 2014-08 ,pp. : 253-264

Karger

Access to resources Recommend Favorite

Natural Killer Cells for Therapy of Leukemia

By  

Transfusion Medicine and Hemotherapy, Vol. 43, Iss. 2, 2016-03 ,pp. : 89-95

Karger

Access to resources Recommend Favorite

Clinical Implications of Natural Killer Cytotoxicity in Patients with Squamous Cell Carcinoma of the Penis

By  

Natural Immunity, Vol. 16, Iss. 5-6, 2000-09 ,pp. : 256-262

Karger

Access to resources Recommend Favorite